Laxaro

View the latest news and breaking news today

astrazeneca gains 5 on marketing nod to launch cancer drug in india - Search

astrazeneca gains 5 on marketing nod to launch cancer drug in india Searched from official sources arount the web with simple content and resource link From any languages in different countries.



astrazeneca gains 5% on marketing nod to launch cancer drug in india




astrazeneca pharma india was up 5% to rs 1,416 on the bse in early morning trade after the company saidit has received approval from the drug controller general of india to market durvalumab, a cancer treatment medicine. “the company has received import & market permission for durvalumab (imfinzit...



astrazeneca's drug extending survival rate in lung cancer patients




astrazeneca’s immunotherapy drug imfinzi has hit a second important goal by improving overall survival in lung cancer patients, boosting prospects for a medicine that has already got off to a promising commercial launch. its success in extending lives, announced by the company on friday, follows d...



biocon and others win drug battle in delhi high court




a two-judge bench of the delhi high court on march 3 lifted an earlier stay order of the same court on the issue of marketing and sale of generic drug biosimilar of roche’s breast cancer drug ‘trastuzumab’ (group name). the appeal was filed by indian pharma major biocon and other pharmaceutic...



cipla gains 3% on final approval for generic pulmicort respules




cipla was up 3.4% to rs 613 on the bse in intra-day trade after the pharmaceutical company announced that it has received a final approval from the us health regulator for generic pulmicort respules used for treatment of asthma.“the company has received final approval for its abbreviated new drug ...



two clovis shareholders accuse cancer drug maker of violating fda rules




patrick mahaffy, president and chief executive officer at clovis oncology in boulder june 1, 2010. (kathryn scott osler / the denver post)two shareholders of clovis oncology (nasdaq: clvs) are accusing the boulder company of regulatory violations during clinical trials for its failed lung cancer dru...



natco a safer bet in volatile pharma pack




the natco pharma stock has been among the few outperformers from the pharma pack and given the recent news flow and the company’s growth prospects, there could be more gains for investors. while natco launched the hepatitis-b drug in india on tuesday, it approved the closure of its qualified insti...



companies claim marijuana makes cancer “commit suicide,” fda loses it




enlarge/ cbd all-natural hemp oil by that's natural! is sold as a supplement but should be regulated as a drug, the fda says. that’s natural! marketing & consultingshare this storythe food and drug administration on wednesday publicly scolded and threatened companies claiming that marijuana-based ...



cipla, roche turn partners for the first time to sell cancer drugs




cipla and roche which fought a bitter legal battle over patent infringement of the latter's lung cancer drug tarceva have turned partners for the first time. on tuesday, the swiss pharma giant roche announced that it had tied up with cipla to distribute its rheumatoid arthritis drug actemra and anti...



kaist team develops technology to find optimum drug target for cancer




image: drug response prediction based on cancer cell molecular network dynamics and clustering of cancer cells by their molecular networks. view more credit: kaista kaist research team led by professor kwang-hyun cho of the department of bio and brain engineering developed technology to find the o...



miracle cancer drug opdivo soon to be available on pbs




miracle drug opdivo, which has an exorbitant price tag, will now be within the reach of all australian renal and cancer patients when it is listed on the pbs. australians fighting late-stage renal and lung cancer will soon have access to miracle drug opdivo in one of the biggest listings on the phar...



dr reddy's gets usfda nod to launch new ovarian cancer drug in us




bs reporter  |  hyderabad  may 18, 2017 last updated at 02:29 ist



orbital atk cygnus set to deliver research to space station




the cygnus spacecraft reenters the earth's atmosphere, as observed by expedition 40 crewmembers aboard the space station. red-data2, a soccer-ball sized companion to a spacecraft reentering the earth's atmosphere, will be a test-bed for the testing and demonstration of high-heat materials. credit: n...



drug maker hikes price of 2-in-1 painkiller >2,000%—$36 drugs now $3,000




enlargegetty | mario tamashare this storyirish drug company horizon pharma has hiked the price of a two-in-one painkiller by more than 2,000 percent in the past five years, according to a report in financial timesa 60-pill bottle of the drug combo, vimovo, cost $138 in 2013 when astrazeneca sold it ...



astrazeneca has started preparations for hard brexit, including operations move




astrazeneca chairman leif johansson. photo: maja suslin/tt anglo-swedish pharmaceutical giant astrazeneca has started preliminary preparations for the possibility of a hard brexit, which would mean moving some of its operations away from the uk, the company's chairman revealed to a swedish newspaper...



clovis drug to be reviewed by european agency




clovis oncology ceo patrick mahaffey (kathryn scott osler / the denver post)the european medicines agency will review an application by boulder's clovis oncology that requests approval for expanded use of the drug rubraca, according to a company news release. rubraca, the company's brand name for th...



targeted 'click-to-release' chemotherapy gives good results in mice




antibody drug conjugates (adcs) are relatively new anti-cancer drugs. they consist of an antibody to which a cell-killing molecule (chemotherapy) is attached. antibodies can recognize and bind to certain receptors (the 'hands' on the outside of a cell) in a very targeted way. the antibody in an adc ...



researchers use sperm to deliver cancer drugs to tumors




sperm offer quite a lot of benefits when it comes to delivering drugs. they're naturally mobile, they can encase the drug so that it doesn't get diluted by body fluids or leak out and they protect the drug from enzymes that can break them down. they also don't cause immune responses like other other...



targeting strategy may open door to better cancer drug delivery




bioengineers may be able to use the unique mechanical properties of diseased cells, such as metastatic cancer cells, to help improve delivery of drug treatments to the targeted cells, according to a team of researchers at penn state.



cancer drug starts clinical trials in human brain-cancer patients




image: pretzel's brain tumor shrank more than 40 percent after treatment with pac-1 in a clinical trial for dogs with glioma, a brain cancer very similar to glioblastoma in humans.... view more credit: photo courtesy tim fanchampaign, ill. -- a drug that spurs cancer cells to self-destruct has bee...



glenmark launches drug for chemotherapy-induced nausea in india, nepal




glenmark pharmaceuticals on thursday launched akynzeo, a drug used for prevention of chemotherapy-induced nausea and vomiting, in india and nepal under an exclusive licensing pact with swiss pharma group, helsinn.akynzeo is an an oral fixed combination of netupitant 300 mg and palonosetron 0.5 mg. i...



in the lab and in the clinic, alisertib with tak-228 excels against solid tumors




image: university of colorado cancer center investigator, jennifer diamond, md, and colleagues report promising phase i results of alisertib with tak-228 against solid tumors including triple-negative breast cancer. view more credit: university of colorado cancer centertwo university of colorado c...



drug combo gangs up to take on triple-negative breast cancer




image: this is jacqueline jeruss, m.d., ph.d., in the lab. view more credit: university of michigan comprehensive cancer center society of surgical oncology, national institutes of health, a sister's hope foundation, saslow family ann arbor, michigan -- in the hunt for novel treatments against an ...



moffitt researchers discover new targets for approved cancer drug




tampa, fla. (oct. 10, 2017) - developing new drugs to treat cancer can be a painstaking process taking over a decade from start to food and drug administration approval. scientists are trying to develop innovative strategies to identify and test new drugs quicker and more efficiently. a team of rese...



researchers discover new targets for approved cancer drug




developing new drugs to treat cancer can be a painstaking process taking over a decade from start to food and drug administration approval. scientists are trying to develop innovative strategies to identify and test new drugs quicker and more efficiently. a team of researchers at moffitt cancer cent...



scientists identify 170 potential lung cancer drug targets using unique cellular




image: from left, dr. bruce posner, dr. michael roth, dr. michael peyton, and dr. john minna were part of the team scientists who identified 170 chemicals for potential new targets to... view more credit: ut southwestern medical centerdallas - april 19, 2018 - after testing more than 200,000 chemi...